Company News in the Life Science Industry

»

Reset 

Hamilton based SteriRight launches N95 Mobile Mask Sanitizing Technology in Response to COVID-19

HAMILTON, ON, July 14, 2020 /CNW/ - N95 masks are recognized to provide the best protection against airborne biological particles but have been in very short supply. To help alleviate this problem, SteriRight is launching its state-of-the-art mobile technology that will allow organizations to... Read more ››

By: PR Newswire Association LLC. - 14 Jul 2020

191,501 Orion Corporation A shares converted into B shares

Read more ››
By: GlobenewsWire - 14 Jul 2020
Related companies:  Orion Corporation

NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis

Read more ››
By: GlobenewsWire - 14 Jul 2020
Related companies:  NMD Pharma

3B Future Health Fund announces new investment in iOnctura

Read more ››
By: GlobenewsWire - 14 Jul 2020

Philips and Flevo Hospital sign long-term strategic partnership agreement enabling continuous innovation and optimization of patient care

Read more ››
By: GlobenewsWire - 14 Jul 2020

Histogen Announces Completion of Patient Enrollment for its HST 001 Phase 1b/2a Trial for Androgenic Alopecia in Men

Read more ››
By: GlobenewsWire - 14 Jul 2020

Press Release Oncology Venture is issuing 2,255,639 shares under its existing convertible loan note agreement with Negma Group LTD and Park Partners GP

Read more ››
By: GlobenewsWire - 14 Jul 2020

New Global Phase 3 Program of BAN2401 Initiated in Preclinical (Asymptomatic) Alzheimer's Disease

STOCKHOLM, July 14, 2020 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that its business partner Eisai, in collaboration with Alzheimer's Clinical Trials Consortium (ACTC) and Biogen, has initiated a new global Phase 3 clinical study (AHEAD 3-45) with BAN2401,... Read more ››

By: PR Newswire Association LLC. - 14 Jul 2020
Related companies:  BioArctic AB

Gerresheimer With Strong Second Quarter

DUESSELDORF, Germany, July 14, 2020 /PRNewswire/ -- Gerresheimer AG delivered profitable growth in the second quarter of 2020. "As a key supplier to the pharma and healthcare industry, we have significant responsibility for ensuring patients worldwide to receive the medication they need.... Read more ››

By: PR Newswire Association LLC. - 14 Jul 2020

iOnctura Extends Series A to EUR 20.1M

- 3B Future Health Fund Joins Blue Chip Investor Syndicate

Read more ››
By: PR Newswire Association LLC. - 14 Jul 2020

Reapplix Receives New Reimbursement Coding and Completes USD 22.6M Equity Financing to Drive US Commercialization

BIRKERØD, Denmark, July 14, 2020 /PRNewswire/ -- Reapplix announces that it has successfully received Medicare reimbursement coding instructions from the Centers for Medicare and Medicaid Services (CMS) with a national average payment rate of USD 1,622.74. The rate covers each patient... Read more ››

By: PR Newswire Association LLC. - 14 Jul 2020

COVID-19 Drug Delivery Devices Market Size Worth $2.15 Billion by 2027: Grand View Research, Inc.

SAN FRANCISCO, July 14, 2020 /PRNewswire/ -- The global Read more ››

By: PR Newswire Association LLC. - 14 Jul 2020

New CRICO Strategies Report Reveals Three Key Clinical Processes that Predict the Likelihood and Amount of Malpractice Indemnity Payments

BOSTON, July 14, 2020 /PRNewswire/ -- CRICO Strategies' new report, The Power to Predict: Leveraging Medical Malpractice Data to Reduce Patient Harm and Financial Loss identifies which breakdowns in clinical processes are the strongest predictors of indemnity payments in malpractice... Read more ››

By: PR Newswire Association LLC. - 14 Jul 2020

IDEAYA to Participate in Fireside Chat at BTIG Biotechnology Conference and Wedbush PacGrow Healthcare Conference on August 11 and 12, 2020

SOUTH SAN FRANCISCO, Calif., July 14, 2020 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced the Company will participate in the following upcoming investor conferences:

... Read more ››
By: PR Newswire Association LLC. - 14 Jul 2020
Related companies:  IDEAYA Biosciences, Inc.

New York Medical College Announces Breakthrough Patent

VALHALLA, N.Y., July 14, 2020 /PRNewswire/ -- Alan Kadish, M.D., president of New York Medical College (NYMC) and Touro College and University System (TCUS), announced patent #10,709,883, issued by the United States Patent and Trademark Office for a revolutionary new bandage using Nano technology.... Read more ››

By: PR Newswire Association LLC. - 14 Jul 2020
Related companies:  New York Medical College (NYMC)

Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia

SAN DIEGO and SAFFRON WALDEN, United Kingdom, July 14, 2020 /PRNewswire/ -- Invivoscribe, Inc., an industry pioneer and global leader in the field of precision diagnostics announces the launch of a fully integrated drug development engine. This new engine will combine with its in-house expertise... Read more ››

By: PR Newswire Association LLC. - 14 Jul 2020
Related companies:  Invivoscribe Technologies, Inc.

Cipla Receives Final Approval for Generic Version of Shire's Firazyr® (Icatibant Injectable Pre-Filled Syringe 30mg/3mL)

MUMBAI, India, July 14, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as ("Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Icatibant Injectable 30mg/3mL from the United States Food and... Read more ››

By: PR Newswire Association LLC. - 14 Jul 2020

Marken Continues Expansion Of Global Footprint

RESEARCH TRIANGLE PARK, N.C., July 14, 2020 /PRNewswire/ -- Marken, the clinical supply chain subsidiary of UPS Healthcare, announced today they are adding a GMP-compliant depot in Los Angeles, California and a new GMP-compliant depot in Kiev, Ukraine. In addition, two GDP-compliant logistics... Read more ››

By: PR Newswire Association LLC. - 14 Jul 2020
Related companies:  Marken LLP | Marken | Marken Philadelphia

Expect a 13 Billion Dollar Molecular Diagnostics Market Due to COVID-19, Says IVD Market Research Firm

ARLINGTON, Va., July 14, 2020 /PRNewswire/ -- The molecular diagnostics market, including new tests for COVID-19, will exceed 13 billion dollars by year's end, according to market research firm Kalorama Information. Kalorama, a market research firm specializing in the in vitro diagnostics market,... Read more ››

By: PR Newswire Association LLC. - 14 Jul 2020

Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans

DENVER, July 14, 2020 /CNW/ -- Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) ("Mydecine" or the "Company"), is pleased to announce that, further to its press release on June 10, 2020, it has entered into a definitive share exchange agreement (the "Share Exchange Agreement")... Read more ››

By: PR Newswire Association LLC. - 14 Jul 2020
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies